Effects of inhibitors of serine protease, phenoloxidase and dopa decarboxylase on the melanization of Dirofilaria immitis microfilariae with Armigeres subalbatus haemolymph in vitro.
The melanization of Dirofilaria immitis microfilariae in Armigeres subalbatus haemolymph in vitro is a two-step process. Firstly, the microfilariae are encased in a transparent capsule, then the capsule material is melanized later. Benzamadine HC1 and p-amidinophenylmethanesulfonyl fluoride, both serine protease inhibitors, inhibited the deposition of the transparent capsule material and melanization. Diethyldithiocarbamate, a phenoloxidase inhibitor, did not prevent the deposition of the transparent capsule material but it did inhibit melanization. m-Hydroxybenzylhydrazine, a dopa decarboxylase inhibitor, had no inhibitory action on the deposition of the transparent capsule material. However, the time for the transparent capsule to become melanized was delayed due to the presence of m-hydroxybenzylhydrazine in the test system. Immmunocytochemical localization showed that propheoloxidase and/or phenoloxidase was present in the transparent capsule material. These results suggest (1) that prophenoloxidase cascade is essential in the melanization of microfilariae in mosquitoes and its putative activation behaviour is similar to that of other insects and (2) that the deposition of transparent capsule material is the result of the activation of prophenoloxidase by serine proteases and the melanization of the transparent capsule material is due to the presence of active phenoloxidase in capsule.
Liu
C T
CT
Department of Parasitology, School of Medicine, National Yangming University, Taipei, Taiwan, Republic of China.
Hou
R F
RF
Ashida
M
M
Chen
C C
CC
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001550:Benzamidines / Q000494:pharmacology; D009033:Culicidae / Q000201:enzymology* / Q000469:parasitology; D004183:Dirofilaria immitis / Q000378:metabolism*; D004050:Ditiocarb / Q000494:pharmacology; D004296:Dopa Decarboxylase / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology; D006458:Hemolymph / Q000201:enzymology*; D006790:Host-Parasite Interactions; D006834:Hydrazines / Q000494:pharmacology; D008543:Melanins / Q000378:metabolism*; D008842:Microfilariae / Q000378:metabolism; D014442:Monophenol Monooxygenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010664:Phenylmethylsulfonyl Fluoride / Q000031:analogs & derivatives / Q000494:pharmacology; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001550:Benzamidines; D004791:Enzyme Inhibitors; D006834:Hydrazines; D008543:Melanins; D015842:Serine Proteinase Inhibitors; D010664:Phenylmethylsulfonyl Fluoride; C027226:(4-amidinophenyl)methanesulfonyl fluoride; D004050:Ditiocarb; C004297:3-hydroxybenzylhydrazine; D014442:Monophenol Monooxygenase; D004296:Dopa Decarboxylase; C032157:benzamidine